Top compounds associated with response to TBCE


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.1 0.008
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.099 0.008
mRNA EHT 1864 GDSC1000 pan-cancer AAC 0.09 0.008
mRNA clofarabine CTRPv2 pan-cancer AAC 0.079 0.009
mRNA dexamethasone CTRPv2 pan-cancer AAC -0.088 0.01
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.096 0.01
mRNA CAY10618 CTRPv2 pan-cancer AAC 0.09 0.01
mRNA FGIN-1-27 CTRPv2 pan-cancer AAC -0.19 0.01
mRNA BRD-A71883111 CTRPv2 pan-cancer AAC 0.095 0.01
mRNA neratinib CTRPv2 pan-cancer AAC -0.09 0.01
Download CSV